UPC Analytics
ENDE
Overview · Filed: —

UPC_APP_17784/2025

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

Procedural & sub-applicationsWithdrawal ApplicationsMilan CDApplication Rop 265—Settled at: Pre-merits
OverviewDecisionsDocumentsTimeline
  • 2025-04-22WithdrawnproceduralApplication Rop 265

    Order by Milan Central Division (UPC_CFI_687/2024, 22 April 2025) permitting Pfizer's withdrawal of the revocation action and counterclaim for revocation against GlaxoSmithKline's EP 4 183 412 (RSV F protein vaccine), and permitting GlaxoSmithKline to withdraw its patent amendment application. 60% court fee reimbursement was granted; each party bears its own costs.